Wendelin Schramm
Wendelin Schramm
GECKO Institue Hochschule Heilbronn
Verified email at
Cited by
Cited by
Epidemiology of complications and total treatment costs from diagnosis of Type 2 diabetes in Germany (ROSSO 4)
S Martin, W Schramm, B Schneider, K Neeser, C Weber, V Lodwig, ...
Experimental and clinical endocrinology & diabetes 115 (08), 495-501, 2007
Integrated personalized diabetes management improves glycemic control in patients with insulin-treated type 2 diabetes: results of the PDM-ProValue study program
B Kulzer, W Daenschel, I Daenschel, W Schramm, D Messinger, ...
diabetes research and clinical practice 144, 200-212, 2018
Screening of diabetic patients for microalbuminuria in primary care—The PROSIT-Project
W Piehlmeier, R Renner, W Schramm, T Kimmerling, S Garbe, ...
Experimental and clinical endocrinology & diabetes 107 (04), 244-251, 1999
Evaluating the ability of economic models of diabetes to simulate new cardiovascular outcomes trials: a report on the ninth mount hood diabetes challenge
L Si, MS Willis, C Asseburg, A Nilsson, M Tew, PM Clarke, M Lamotte, ...
Value in Health 23 (9), 1163-1170, 2020
Cost effectiveness of combination therapy with pioglitazone for type 2 diabetes mellitus from a German statutory healthcare perspective
K Neeser, G Lübben, U Siebert, W Schramm
Pharmacoeconomics 22, 321-341, 2004
The challenge of transparency and validation in health economic decision modelling: a view from Mount Hood
S Kent, F Becker, T Feenstra, A Tran-Duy, I Schlackow, M Tew, P Zhang, ...
Pharmacoeconomics 37, 1305-1312, 2019
Cost-effectiveness analysis of a quality-controlled mammography screening program from the Swiss statutory health-care perspective: quantitative assessment of the most …
K Neeser, T Szucs, JL Bulliard, G Bachmann, W Schramm
Value in health 10 (1), 42-53, 2007
A method for using real world data in breast cancer modeling
M Pobiruchin, S Bochum, UM Martens, M Kieser, W Schramm
Journal of biomedical informatics 60, 385-394, 2016
Integrated personalized diabetes management (PDM) design of the ProValue studies: Prospective, cluster-randomized, controlled, intervention trials for evaluation of the …
B Kulzer, W Daenschel, I Daenschel, EG Siegel, W Schramm, CG Parkin, ...
Journal of diabetes science and technology 10 (3), 772-781, 2016
Opportunities and barriers to the development and use of open source health economic models: a survey
XGLV Pouwels, CJ Sampson, RJG Arnold, MD Janodia, R Henderson, ...
Value in health 25 (4), 473-479, 2022
Benefit of digital tools used for integrated personalized diabetes management: results from the PDM-ProValue study program
L Heinemann, W Schramm, H Koenig, A Moritz, I Vesper, J Weissmann, ...
Journal of diabetes science and technology 14 (2), 240-249, 2020
PROSIT Open Source Disease Models for Diabetes Mellitus.
W Schramm, F Sailer, M Pobiruchin, C Weiss
ICIMTH, 115-118, 2016
Economic value of tiotropium in the treatment of chronic obstructive pulmonary disease
W Schramm, D Haake, A Brandt
Praxis 94 (46), 1803-1810, 2005
Assessment of SARS-CoV-2 infection among healthcare workers of a German COVID-19 treatment center
L Larribère, J Gordejeva, L Kuhnhenn, M Kurscheidt, M Pobiruchin, ...
International Journal of Environmental Research and Public Health 18 (13), 7057, 2021
Prediction of 5-Year Survival with Data Mining Algorithms.
F Sailer, M Pobiruchin, S Bochum, UM Martens, W Schramm
ICIMTH, 75-78, 2015
Exploring structural uncertainty and impact of health state utility values on lifetime outcomes in diabetes economic simulation models: findings from the Ninth Mount Hood …
M Tew, M Willis, C Asseburg, H Bennett, A Brennan, T Feenstra, J Gahn, ...
Medical Decision Making 42 (5), 599-611, 2022
35th annual meeting of the European Association for the Study of diabetes: Brussels, Belgium, 28 September–2 October 1999
A Melander, J Olsson, G Lindberg, A Salzman, T Howard, P Stang, ...
Diabetologia 42, A1-A330, 1999
Digital diabetes self-management: a trilateral serial
W Schramm
Journal of Diabetes Science and Technology 12 (3), 709-711, 2018
Integrated personalized diabetes management (iPDM) in patients with insulin-treated T2DM: Results of the PDM-ProValue study program
L Heinemann, I Daenschel, W Dänschel, D Messinger, W Schramm, ...
11th International Conference on Advanced Technologies & Treatments for …, 2018
Regionale Analyse der medikamentösen Behandlungsprävalenz und Arzneimitteltherapie von Diabetes mellitus in Deutschland
T Willert, J Walker, W Schramm
DMW-Deutsche Medizinische Wochenschrift 137 (46), 2363-2368, 2012
The system can't perform the operation now. Try again later.
Articles 1–20